INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Ikarian Capital, LLC's Holding History (CIK: 0001778253)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 160,200 Value ($000) $1,772 Avg Close — Range —
Q1 2023
Shares 85,200 Value ($000) $1,144 Avg Close — Range —
Q4 2022
Shares 85,200 Value ($000) $1,054 Avg Close — Range —
Q3 2022
Shares 85,200 Value ($000) $1,189 Avg Close — Range —
Q2 2022
Shares 105,000 Value ($000) $1,449 Avg Close — Range —
Q1 2022
Shares 35,149 Value ($000) $572 Avg Close — Range —
Q4 2021
Shares 34,565 Value ($000) $562 Avg Close — Range —
Q3 2021
Shares 34,565 Value ($000) $513 Avg Close — Range —
Q2 2021
Shares 35,000 Value ($000) $700 Avg Close — Range —
Q1 2021
Shares 35,000 Value ($000) $808 Avg Close — Range —